相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ubiquitin proteasome system - Implications for cell cycle control and the targeted treatment of cancer
Florian Bassermann et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2014)
Degrasyn-like symmetrical compounds: Possible therapeutic agents for multiple myeloma (MM-I)
Zhenghong Peng et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2014)
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells
Yanyan Gu et al.
BLOOD (2014)
Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia
Mark J. Kiel et al.
BLOOD (2014)
Notch signaling: switching an oncogene to a tumor suppressor
Camille Lobry et al.
BLOOD (2014)
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
Paul G. Richardson et al.
BLOOD (2014)
CYLD coordinates with EB1 to regulate microtubule dynamics and cell migration
Dengwen Li et al.
CELL CYCLE (2014)
Polycomb Repressive Complex 2 Regulates Normal Hematopoietic Stem Cell Function in a Developmental-Stage-Specific Manner
Huafeng Xie et al.
CELL STEM CELL (2014)
NF-κB pathways in hematological malignancies
Chiara Gasparini et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Characteristics of A20 gene polymorphisms in T-cell acute lymphocytic leukemia
Lihua Zhu et al.
HEMATOLOGY (2014)
The deubiquitinase U5P28 controls intestinal homeostasis and promotes colorectal cancer
Markus E. Diefenbacher et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients
S. Jeromin et al.
LEUKEMIA (2014)
A20 in inflammation and autoimmunity
Leen Catrysse et al.
TRENDS IN IMMUNOLOGY (2014)
Regulation and Role of EZH2 in Cancer
Hirohito Yamaguchi et al.
CANCER RESEARCH AND TREATMENT (2014)
EZH2 mutations are frequent and represent an early event in follicular lymphoma
Csaba Boedoer et al.
BLOOD (2013)
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma
Barbara Meissner et al.
BLOOD (2013)
EZH2 Is Required for Germinal Center Formation and Somatic EZH2 Mutations Promote Lymphoid Transformation
Wendy Beguelin et al.
CANCER CELL (2013)
Germinal center dysregulation by histone methyltransferase EZH2 promotes lymphomagenesis
Marieta Caganova et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
SCFFbxo9 and CK2 direct the cellular response to growth factor withdrawal via Tel2/Tti1 degradation and promote survival in multiple myeloma
Vanesa Fernandez-Saiz et al.
NATURE CELL BIOLOGY (2013)
A20 Restricts Wnt Signaling in Intestinal Epithelial Cells and Suppresses Colon Carcinogenesis
Ling Shao et al.
PLOS ONE (2013)
Regulation of T cell function by the ubiquitin-specific protease USP9X via modulating the Carma1-Bcl10-Malt1 complex
Yoon Park et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Related F-box proteins control cell death in Caenorhabditis elegans and human lymphoma
Michael Chiorazzi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Smurf2 suppresses B-cell proliferation and lymphomagenesis by mediating ubiquitination and degradation of YY1
Charusheila Ramkumar et al.
NATURE COMMUNICATIONS (2013)
CBL mutation in chronic myelomonocytic leukemia secondary to familial platelet disorder with propensity to develop acute myeloid leukemia (FPD/AML)
Norio Shiba et al.
BLOOD (2012)
F-box protein FBXL2 targets cyclin D2 for ubiquitination and degradation to inhibit leukemic cell proliferation
Bill B. Chen et al.
BLOOD (2012)
Deletion of the TNFAIP3/A20 gene detected by FICTION analysis in classical Hodgkin lymphoma
Junko Nomoto et al.
BMC CANCER (2012)
Smurf2 Regulates the Senescence Response and Suppresses Tumorigenesis in Mice
Charusheila Ramkumar et al.
CANCER RESEARCH (2012)
TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes
Thorkell Gudjonsson et al.
CELL (2012)
EDD induces cell cycle arrest by increasing p53 levels
Veronique A. J. Smits
CELL CYCLE (2012)
Roles of ubiquitin signaling in transcription regulation
Ian Hammond-Martel et al.
CELLULAR SIGNALLING (2012)
The diverse roles of IRF4 in late germinal center B-cell differentiation
Nilushi S. De Silva et al.
IMMUNOLOGICAL REVIEWS (2012)
Roles of BCL6 in normal and transformed germinal center B cells
Katia Basso et al.
IMMUNOLOGICAL REVIEWS (2012)
Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination
Michael Millward et al.
INVESTIGATIONAL NEW DRUGS (2012)
The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development
Davide Rossi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma
Mark J. Kiel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
FBXO11 targets BCL6 for degradation and is inactivated in diffuse large B-cell lymphomas
Shanshan Duan et al.
NATURE (2012)
Fbxw7α- and GSK3-mediated degradation of p100 is a pro-survival mechanism in multiple myeloma
Luca Busino et al.
NATURE CELL BIOLOGY (2012)
Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis
Fabiola Traina et al.
PLOS ONE (2012)
CANCER SCF-Mediated Degradation of p100 (NF-κB2): Mechanisms and Relevance in Multiple Myeloma
Luca Busino et al.
SCIENCE SIGNALING (2012)
SCF ubiquitin ligases in the maintenance of genome stability
Joshua S. Silverman et al.
TRENDS IN BIOCHEMICAL SCIENCES (2012)
Multiple degradation pathways regulate versatile CIP/KIP CDK inhibitors
Natalia G. Starostina et al.
TRENDS IN CELL BIOLOGY (2012)
Forced Mitotic Entry of S-Phase Cells as a Therapeutic Strategy Induced by Inhibition of WEE1
Marieke Aarts et al.
CANCER DISCOVERY (2012)
A20: linking a complex regulator of ubiquitylation to immunity and human disease
Averil Ma et al.
NATURE REVIEWS IMMUNOLOGY (2012)
A novel small molecule deubiquitinase inhibitor blocks Jak2 signaling through Jak2 ubiquitination
Vaibhav Kapuria et al.
CELLULAR SIGNALLING (2011)
Knockdown of Fbxo7 reveals its regulatory role in proliferation and differentiation of haematopoietic precursor cells
El Kahina Meziane et al.
JOURNAL OF CELL SCIENCE (2011)
Tumor suppressor TNFAIP3 (A20) is frequently deleted in Sezary syndrome
F. C. M. Braun et al.
LEUKEMIA (2011)
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia
Apostolos Klinakis et al.
NATURE (2011)
Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death
Domagoj Vucic et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis
Mikhail Lomonosov et al.
PLOS ONE (2011)
A High Occurrence of Acquisition and/or Expansion of C-CBL Mutant Clones in the Progression of High-Risk Myelodysplastic Syndrome to Acute Myeloid Leukemia
Hsiao-Wen Kao et al.
NEOPLASIA (2011)
Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells
Katia Basso et al.
BLOOD (2010)
Mutations of an E3 ubiquitin ligase c-Cbl but not TET2 mutations are pathogenic in juvenile myelomonocytic leukemia
Hideki Muramatsu et al.
BLOOD (2010)
A novel orally active proteasome inhibitor ONX 0912 triggers in vitro and in vivo cytotoxicity in multiple myeloma
Dharminder Chauhan et al.
BLOOD (2010)
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-κB-dependent lymphoma
Michael A. Milhollen et al.
BLOOD (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
The Notch/Hes1 Pathway Sustains NF-κB Activation through CYLD Repression in T Cell Leukemia
Lluis Espinosa et al.
CANCER CELL (2010)
Deubiquitinase Inhibition by Small-Molecule WP1130 Triggers Aggresome Formation and Tumor Cell Apoptosis
Vaibhav Kapuria et al.
CANCER RESEARCH (2010)
CYLD: a tumor suppressor deubiquitinase regulating NF-kappa B activation and diverse biological processes
S-C Sun
CELL DEATH AND DIFFERENTIATION (2010)
CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulin
Sara A. Wickstroem et al.
EMBO JOURNAL (2010)
A20 is targeted by promoter methylation, deletion and inactivating mutation in MALT lymphoma
E. Chanudet et al.
LEUKEMIA (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
CBL mutations in juvenile myelomonocytic leukemia and pediatric myelodysplastic syndrome
N. Shiba et al.
LEUKEMIA (2010)
Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival
Martin Schwickart et al.
NATURE (2010)
Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia
Charlotte M. Niemeyer et al.
NATURE GENETICS (2010)
Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
Ryan D. Morin et al.
NATURE GENETICS (2010)
Mechanisms of Disease: Aggressive Lymphomas.
Georg Lenz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The ubiquitous nature of cancer: the role of the SCFFbw7 complex in development and transformation
K. M. Crusio et al.
ONCOGENE (2010)
TRAF6 and A20 Regulate Lysine 63-Linked Ubiquitination of Beclin-1 to Control TLR4-Induced Autophagy
Chong-Shan Shi et al.
SCIENCE SIGNALING (2010)
Ubiquitination and Degradation of the Inhibitors of NF-κB
Naama Kanarek et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
A20: from ubiquitin editing to tumour suppression
Sarah G. Hymowitz et al.
NATURE REVIEWS CANCER (2010)
Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells
Emanuela Rosati et al.
BLOOD (2009)
The NF-κB negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas
Urban Novak et al.
BLOOD (2009)
TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas
Keiichiro Honma et al.
BLOOD (2009)
The BCL6 transcriptional program features repression of multiple oncogenes in primary B cells and is deregulated in DLBCL
Weimin Ci et al.
BLOOD (2009)
Mutations in CBL occur frequently in juvenile myelomonocytic leukemia
Mignon L. Loh et al.
BLOOD (2009)
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
Francis H. Grand et al.
BLOOD (2009)
Ubiquitin-mediated control of oncogene and tumor suppressor gene products
Kyoko Kitagawa et al.
CANCER SCIENCE (2009)
Update of Cylindromatosis Gene (CYLD) Mutations in Brooke-Spiegler Syndrome: Novel Insights Into the Role of Deubiquitination in Cell Signaling
Patrick W. Blake et al.
HUMAN MUTATION (2009)
Some Lessons from My Work on the Biochemistry of the Ubiquitin System
Avram Hershko
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma
Roland Schmitz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Mara Compagno et al.
NATURE (2009)
Frequent inactivation of A20 in B-cell lymphomas
Motohiro Kato et al.
NATURE (2009)
Gain-of-function of mutated C-CBL tumour suppressor in myeloid neoplasms
Masashi Sanada et al.
NATURE (2009)
The NF-κB Family of Transcription Factors and Its Regulation
Andrea Oeckinghaus et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2009)
BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells
Stella A. Ranuncolo et al.
BLOOD CELLS MOLECULES AND DISEASES (2008)
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies
Andrew J. Dunbar et al.
CANCER RESEARCH (2008)
Tumor suppressor CYLD: negative regulation of NF-kappa B signaling and more
G. Courtois
CELLULAR AND MOLECULAR LIFE SCIENCES (2008)
Function and regulation of protein neddylation - 'Protein Modifications: Beyond the Usual Suspects' review series
Gwenael Rabut et al.
EMBO REPORTS (2008)
Exon 8 splice site mutations in the gene encoding the E3-ligase CBL are associated with core binding factor acute myeloid leukemias
Saman Abbas et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2008)
The tumor suppressor CYLD regulates microtubule dynamics and plays a role in cell migration
Jinmin Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Discovery of a potent, selective, and orally active proteasome inhibitor for the treatment of cancer
Bruce D. Dorsey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
FBXW7 mutation in adult T-cell and B-cell acute lymphocytic leukemias
Jee Hoon Song et al.
LEUKEMIA RESEARCH (2008)
Deregulated proteolysis by the F-box proteins SKP2 and β-TrCP:: tipping the scales of cancer
David Frescas et al.
NATURE REVIEWS CANCER (2008)
CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib
Roberto Piva et al.
BLOOD (2008)
Constitutively activated STAT3 promotes cell proliferation and survival in the activated B-cell subtype of diffuse large B-cell lymphomas
B. Belinda Ding et al.
BLOOD (2008)
Deubiquitylation and regulation of the immune response
Shao-Cong Sun
NATURE REVIEWS IMMUNOLOGY (2008)
Cylindromatosis and the CYLD gene:: new lessons on the molecular principles of epithelial growth control
Ramin Massoumi et al.
BIOESSAYS (2007)
Conditional inactivation of Fbxw7 impairs cell-cycle exit during T cell differentiation and results in lymphomatogenesis
Ichiro Onoyama et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myelorna
Deborah J. Kuhn et al.
BLOOD (2007)
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia
Benjamin J. Thompson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Flt3-dependent transformation by inactivating c-Cbl mutations in AML
Buelent Sargin et al.
BLOOD (2007)
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia
Michael A. Caligiuri et al.
BLOOD (2007)
Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR
Stella Maris Ranuncolo et al.
NATURE IMMUNOLOGY (2007)
NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells
Claudia P. Miller et al.
BLOOD (2007)
The tumor suppressor CYLD regulates entry into mitosis
Frank Stegmeier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Deregulated NF-κB activity in haematological malignancies
Aurore Keutgens et al.
BIOCHEMICAL PHARMACOLOGY (2006)
The Cbl family proteins: Ring leaders in regulation of cell signaling
Gayathri Swaminathan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib
Paul G. Richardson et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
AP Bracken et al.
GENES & DEVELOPMENT (2006)
Ubiquitin ligases: cell-cycle control and cancer
KI Nakayama et al.
NATURE REVIEWS CANCER (2006)
Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20
RT Lin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Mcl-1 is overexpressed in multiple myeloma and associated with relapse and shorter survival
S Wuillème-Toumi et al.
LEUKEMIA (2005)
Bortezomib or high-dose dexamethasone for relapsed multiple myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Structure-activity relationship studies of salinosporamide a (NPI-0052), a novel marine derived proteasome inhibitor
VR Macherla et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Regulation of the cell cycle by SCF-type ubiquitin ligases
KI Nakayama et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2005)
A20 is a negative regulator of IFN regulatory factor 3 signaling
T Saitoh et al.
JOURNAL OF IMMUNOLOGY (2005)
Phase II clinical experience with the novel proteasome inhibitor bortezomib in patients with indolent non-Hodgkin's lymphoma and mantle cell lymphoma
OA O'Connor et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase II study of proteasome inhibitor bortezomib in relapsed or refractory B-Cell non-Hodgkin's lymphoma
A Goy et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The ubiquitin of its roles in system for protein degradation and some the control of the cell-division cycle - (Nobel Lecture)
A Hershko
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
Mechanism of processing of the NF-κB2 p100 precursor:: identification of the specific polyubiquitin chain-anchoring lysine residue and analysis of the role of NEDD8-modification on the SCFβ-TrCP ubiquitin ligase
RE Amir et al.
ONCOGENE (2004)
The SCF ubiquitin ligase: Insights into a molecular machine
T Cardozo et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation
C Tunyaplin et al.
JOURNAL OF IMMUNOLOGY (2004)
Dual effects of I kappa B kinase beta-mediated phosphorylation on p105 fate: SCF beta-TrCP-dependent degradation an SCF beta-TrCP-independent processing
S Cohen et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Skp2-dependent degradation of p27kip1 is essential for cell cycle progression
U Kossatz et al.
GENES & DEVELOPMENT (2004)
Systematic analysis and nomenclature of mammalian F-box proteins
JP Jin et al.
GENES & DEVELOPMENT (2004)
Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity
D Pasini et al.
EMBO JOURNAL (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Skp2-mediated degradation of p27 regulates progression into mitosis
K Nakayama et al.
DEVELOPMENTAL CELL (2004)
Degradation of p57Kip2 mediated by SCFSkp2 -: dependent ubiquitylation
T Kamura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Prognostic significance of the F-box protein Skp2 expression in diffuse large B-cell lymphoma
R Seki et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase
G Bornstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
A phase 2 study of bortezomib in relapsed, refractory myeloma
PG Richardson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Structure of a β-TrCP1-Skp1-β-catenin complex:: Destruction motif binding and lysine specificity of the SCFβ-TrCP1 ubiquitin ligase
G Wu et al.
MOLECULAR CELL (2003)
Cell cycle checkpoint signaling: Cell cycle arrest versus apoptosis
JA Pietenpol et al.
TOXICOLOGY (2002)
Expression of Skp2, a p27Kip1 ubliquitin ligase, in malignant lymphoma:: correlation with p27Kip1 and proliferation index
MS Lim et al.
BLOOD (2002)
c-MYC: More than just a matter of life and death
S Pelengaris et al.
NATURE REVIEWS CANCER (2002)
The ubiquitin-proteasome proteolytic pathway: Destruction for the sake of construction
MH Glickman et al.
PHYSIOLOGICAL REVIEWS (2002)
The Polycomb-group gene Ezh2 is required for early mouse development
D O'Carroll et al.
MOLECULAR AND CELLULAR BIOLOGY (2001)
Role of the F-box protein Skp2 in lymphomagenesis
E Latres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Commitment of B lymphocytes to a plasma cell fate is associated with Blimp-1 expression in vivo
C Angelin-Duclos et al.
JOURNAL OF IMMUNOLOGY (2000)
Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases
N Zheng et al.
CELL (2000)
BCL-6 represses genes that function in lymphocyte differentiation, inflammation, and cell cycle control
AL Shaffer et al.
IMMUNITY (2000)
Ubiquitin-proteasome system and increased sensitivity of B-CLL lymphocytes to apoptotic death activation
P Masdehors et al.
LEUKEMIA & LYMPHOMA (2000)
Identification of the familial cylindromatosis tumour-suppressor gene
GR Bignell et al.
NATURE GENETICS (2000)
SCFβ-TrcP ubiquitin ligase-mediated processing of NF-κB p105 requires phosphorylation of its C-terminus by IκB kinase
A Orian et al.
EMBO JOURNAL (2000)
c-Myc proteolysis by the ubiquitin-proteasome pathway: Stabilization of c-Myc in Burkitt's lymphoma cells
MA Gregory et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
